3 results
Approved WMORecruitment stopped
Primary objective:To demonstrate that the mean change from baseline in Best Corrected Visual Acuity (BCVA) over a 12 month treatment period obtained with either a 0.5 mg ranibizumab *Treat and Extend* (TE) dosing regimen with adjunctive laser, and/…
Approved WMORecruiting
To evaluate the effect of lidocaine temperature on pain perception during infiltration for upper blepharoplasty.
Approved WMORecruiting
To demonstrate that DMEK is superior to DSAEK with respect to visual acuity and quality of vision.